Published in J Infect Dis on July 01, 1980
Defense mechanisms involving Fc-dependent functions of immunoglobulin A and their subversion by bacterial immunoglobulin A proteases. Microbiol Rev (1988) 2.50
Oral microbial ecology and the role of salivary immunoglobulin A. Microbiol Mol Biol Rev (1998) 1.81
Gonococcal pilus vaccine. Studies of antigenicity and inhibition of attachment. J Clin Invest (1981) 1.62
Analysis of the antigen specificity of the human serum immunoglobulin G immune response to complicated gonococcal infection. Infect Immun (1984) 1.36
Molecular basis for serum resistance in Neisseria gonorrhoeae. Clin Microbiol Rev (1989) 1.32
Interactions of Neisseria gonorrhoeae with human neutrophils. Clin Microbiol Rev (1989) 1.29
Structural and serological relatedness of Haemophilus influenzae type b pili. Infect Immun (1988) 1.18
Genital antibody response to a parenteral gonococcal pilus vaccine. Infect Immun (1982) 1.14
Structure and function of pili of pathogenic Neisseria species. Clin Microbiol Rev (1989) 1.12
Resistance of Neisseria gonorrhoeae to neutrophils. Front Microbiol (2011) 1.06
Specificity of antibodies against Neisseria gonorrhoeae that stimulate neutrophil chemotaxis. Role of antibodies directed against lipooligosaccharides. J Clin Invest (1987) 1.00
Is gonococcal disease preventable? The importance of understanding immunity and pathogenesis in vaccine development. Crit Rev Microbiol (2016) 0.87
The specificity of serum and local antibodies in female gonorrhoea. Clin Exp Immunol (1986) 0.86
Humoral immune response to gonococcal infections. Clin Microbiol Rev (1989) 0.86
Cellular immune responses during gonococcal and meningococcal infections. Clin Microbiol Rev (1989) 0.79
Serovar specific immunity to Neisseria gonorrhoeae: does it exist? Genitourin Med (1995) 0.77
Gonorrhea - an evolving disease of the new millennium. Microb Cell (2016) 0.75
The structure, function, synthesis and genetic control of bacterial pili and a molecular model for DNA and RNA transport in gram negative bacteria. Trans N Y Acad Sci (1965) 20.37
Immunologic response of man to group B meningococcal polysaccharide vaccines. J Infect Dis (1972) 4.54
The properties of sex pili, the viral nature of "conjugal" genetic transfer systems, and some possible approaches to the control of bacterial drug resistance. CRC Crit Rev Microbiol (1971) 4.40
In vitro adhesion of Escherichia coli to porcine small intestinal epithelial cells: pili as adhesive factors. Infect Immun (1978) 3.13
Immunization of suckling pigs against enteric enterotoxigenic Escherichia coli infection by vaccinating dams with purified pili. Infect Immun (1978) 2.94
Mechanical removal of F pili, type I pili, and flagella from Hfr and RTF donor cells and the kinetics of their reappearance. J Bacteriol (1969) 2.87
Genetic complementation analysis of Escherichia coli type 1 somatic pilus mutants. J Bacteriol (1977) 2.77
Identification and characterization of E. coli type-1 pilus tip adhesion protein. Nature (1988) 2.71
Effect of spectinomycin use on the prevalence of spectinomycin-resistant and of penicillinase-producing Neisseria gonorrhoeae. N Engl J Med (1987) 2.70
Isolation and characterization of Escherichia coli phase variants and mutants deficient in type 1 pilus production. J Bacteriol (1977) 2.67
Gonococcal pilin variants in experimental gonorrhea. J Exp Med (1987) 2.62
Iminobiotin affinity columns and their application to retrieval of streptavidin. Proc Natl Acad Sci U S A (1980) 2.57
Antigenic and physical diversity of Neisseria gonorrhoeae lipooligosaccharides. Infect Immun (1986) 2.55
Serologic studies of meningococcal infection and polysaccharide vaccination. J Infect Dis (1971) 2.54
Immunization of suckling pigs against enterotoxigenic Escherichia coli-induced diarrheal disease by vaccinating dams with purified 987 or K99 pili: protection correlates with pilus homology of vaccine and challenge. Infect Immun (1978) 2.52
The Walter Reed staging classification for HTLV-III/LAV infection. N Engl J Med (1986) 2.44
Seronegative secondary syphilis in a patient infected with the human immunodeficiency virus (HIV) with Kaposi sarcoma. A diagnostic dilemma. Ann Intern Med (1987) 2.35
Persistence of Treponema pallidum following penicillin G therapy. Report of two cases. JAMA (1976) 2.31
Cross-reactivity of Neisseria gonorrhoeae and Neisseria meningitidis and the nature of antigens involved in the bactericidal reaction. J Infect Dis (1974) 2.24
Inhibition of bacterial conjugation by ribonucleic acid and deoxyribonucleic acid male-specific bacteriophages. J Bacteriol (1968) 2.10
Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile. Chilean National Committee for Meningococcal Disease. Vaccine (1995) 2.06
Expression of outer membrane protein II by gonococci in experimental gonorrhea. J Exp Med (1988) 2.01
Variability of the lytic susceptibility of Neisseria gonorrhoeae to human sera. J Immunol (1977) 1.81
Evaluation of immunotherapeutic approaches for the potential treatment of infections caused by K1-positive Escherichia coli. J Infect Dis (1983) 1.73
Neisseria meningitidis group B correlates of protection and assay standardization--international meeting report Emory University, Atlanta, Georgia, United States, 16-17 March 2005. Vaccine (2006) 1.67
Gonococcal pilus vaccine. Studies of antigenicity and inhibition of attachment. J Clin Invest (1981) 1.62
Inhibition of adherence of Neisseria gonorrhoeae by human genital secretions. J Clin Invest (1977) 1.61
Increased antibiotic resistance of Neisseria gonorrhoeae in Korea. Antimicrob Agents Chemother (1976) 1.58
A comparison of the variable antigens expressed by clone IV-1 and subgroup III of Neisseria meningitidis serogroup A. J Infect Dis (1992) 1.56
Chloroquine: mode of action. Science (1966) 1.55
Efficacy trial of a parenteral gonococcal pilus vaccine in men. Vaccine (1991) 1.50
A monoclonal antibody against meningococcus group B polysaccharides distinguishes embryonic from adult N-CAM. J Cell Biol (1986) 1.42
Purification of the Escherichia coli type 1 pilin and minor pilus proteins and partial characterization of the adhesin protein. J Bacteriol (1988) 1.39
Syphilis in the AIDS era. N Engl J Med (1987) 1.37
Specific interaction of the tetragonally arrayed protein layer of Bacillus sphaericus with its peptidoglycan sacculus. J Bacteriol (1979) 1.34
Specificity of inhibition of epithelial cell adhesion of Neisseria gonorrhoeae. Infect Immun (1976) 1.33
Quantitative relationship between capsular content and killing of K1-encapsulated Escherichia coli. Infect Immun (1988) 1.32
Identification of the structural gene for F-pilin. J Mol Biol (1976) 1.30
A prospective randomized trial of ofloxacin vs. doxycycline in the treatment of uncomplicated male urethritis. Sex Transm Dis (1989) 1.28
Elimination of resistance determinants from R-factor R1 by intercalative compounds. Antimicrob Agents Chemother (1976) 1.27
Reactogenicity, immunogenicity and efficacy studies of Escherichia coli type 1 somatic pili parenteral vaccine in man. Scand J Infect Dis Suppl (1982) 1.26
A study of particle sizes, shapes and toxicities present in a boivin-type endotoxic preparation. Ann N Y Acad Sci (1966) 1.24
Functions of F pili in mating-pair formation and male bacteriophage infection studies by blending spectra and reappearance kinetics. J Bacteriol (1969) 1.24
Meningococcal infections. 3. Studies of group A polysaccharide vaccines. Bull World Health Organ (1971) 1.23
Inhibition of clinically significant bacterial organisms in vitro by 2-acetylpyridine thiosemicarbazones. Antimicrob Agents Chemother (1980) 1.23
The problems of drug-resistant pathogenic bacteria. Elimination of bacterial episomes by DNA-complexing compounds. Ann N Y Acad Sci (1971) 1.22
Latex agglutination test for measurement of antibodies to meningococcal polysaccharides. Infect Immun (1972) 1.21
Isolation, characterization, and in vitro assembly of the tetragonally arrayed layer of Bacillus sphaericus. J Bacteriol (1979) 1.21
Simple method for detection of penicillinase-producing Neisseria gonorrhoeae. J Clin Microbiol (1978) 1.20
Functional activities of monoclonal antibodies to the O side chain of Escherichia coli lipopolysaccharides in vitro and in vivo. J Infect Dis (1988) 1.19
Relative inefficiency of soluble recombinant CD4 for inhibition of infection by monocyte-tropic HIV in monocytes and T cells. J Immunol (1990) 1.18
Removal of the coat protein of bacteriophages M13 or fd from the exterior of the host after infection. Virology (1971) 1.15
Genital antibody response to a parenteral gonococcal pilus vaccine. Infect Immun (1982) 1.14
The threat of infectious disease in Americans returning from Operation Desert Storm. N Engl J Med (1991) 1.14
Human bactericidal antibody response to meningococcal outer membrane protein vaccines. Antonie Van Leeuwenhoek (1987) 1.13
Clinical correlation of strain differentiation of Neisseria gonorrhoeae. J Infect Dis (1976) 1.13
Age-specific prevalence of serum antibodies to the invasion plasmid and lipopolysaccharide antigens of Shigella species in Chilean and North American populations. J Infect Dis (1992) 1.09
Serological and functional properties of monoclonal antibodies to Escherichia coli type I pilus and capsular antigens. Prog Allergy (1983) 1.06
Cloning and expression in Escherichia coli of LKP pilus genes from a nontypeable Haemophilus influenzae strain. Infect Immun (1990) 1.06
Quinacrine (atebrin): mode of action. Science (1967) 1.06
Meningococcal serogroup B vaccine protection trial and follow-up studies in Chile. The Chilean National Committee for Meningococcal Disease. NIPH Ann (1991) 1.05
The infection of Pseudomonas aeruginosa by RNA pilus phage PP7: the adsorption organelle and the relationship between phage sensitivity and the division cycle. Virology (1971) 1.04
Prevention and therapy of experimental Escherichia coli infection with monoclonal antibody. Infect Immun (1985) 1.02
Evaluation of pilus vaccines for prevention of experimental otitis media caused by nontypable Haemophilus influenzae. Pediatr Infect Dis J (1989) 1.01
Naturally occurring toxins in feedstuffs: Center for Veterinary Medicine Perspective. J Anim Sci (1993) 0.98
Differences in attachment antigens of gonococci in reinfection. J Lab Clin Med (1979) 0.98
Gene conversion accounts for pilin structural changes and for reversible piliation "phase" changes in gonococci. Antonie Van Leeuwenhoek (1987) 0.95
Safety and antigenicity of typhoid-Shigella sonnei vaccine (strain 5076-1C). J Infect Dis (1984) 0.95
Structural relationships and sialylation among meningococcal L1, L8, and L3,7 lipooligosaccharide serotypes. J Biol Chem (2000) 0.94
Pilus vaccines. Vaccine (1985) 0.91
Human immunization with Pgh 3-2 gonococcal pilus results in cross-reactive antibody to the cyanogen bromide fragment-2 of pilin. J Infect Dis (1991) 0.90
Failure of routine methods in the diagnosis of chronic brucellosis. South Med J (1979) 0.90
Utility of the VDRL test in HIV-seropositive patients. N Engl J Med (1990) 0.88
UTILIZATION OF CARBOHYDRATES AND METABOLIC INTERMEDIATES BY PILIATED AND NONPILIATED BACTERIA. J Bacteriol (1962) 0.88
Studies on modes of action of chloroquine, quinacrine, and quinine and on chloroquine resistance. Mil Med (1966) 0.87
Variations in buccal cell adhesion of Neisseria gonorrhoeae. Infect Immun (1977) 0.85
Infection of Pseudomonas aeruginosa spheroplasts by RNA from a pilus phage. Virology (1970) 0.84
Comparison of phlebitis produced by cephapirin and cephalothin. Antimicrob Agents Chemother (1976) 0.83
Synthetic trehalose dicorynomycolate (S-TDCM): behavioral effects and radioprotection. J Radiat Res (1997) 0.83
Recent advances in otitis media. Microbiology, immunology, biochemistry, and vaccination. Ann Otol Rhinol Laryngol Suppl (1989) 0.83
Generalized chronic dermatophytosis in patients with human immunodeficiency virus type I infection and CD4 depletion. Arch Dermatol (1991) 0.82
Surveillance of Salmonella prevalence in animal feeds and characterization of the Salmonella isolates by serotyping and antimicrobial susceptibility. Foodborne Pathog Dis (2012) 0.82
Adhesion of Neisseria gonorrhoeae and disease. Ciba Found Symp (1981) 0.82
Serological study of meningococcal isolates in Switzerland and France 1980-1986. Eur J Clin Microbiol Infect Dis (1988) 0.81
Neurosyphilis in patients with human immunodeficiency virus infection. N Engl J Med (1995) 0.81
Soluble CD4: the first step. Ann Intern Med (1990) 0.80
Expression of class 5 antigens by meningococcal strains obtained from patients in Brazil and evaluation of two new monoclonal antibodies. Braz J Infect Dis (2001) 0.79